.
BioEnterprise

OptiKira Raises $3.7 Million

OptiKira, a BioMotiv spinoff company developing treatments for blindness and other diseases caused by progressive cell death, raised $3.7 million. The investment will be used for the development of drugs for the treatment of degenerative eye diseases.

Read More  >